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Abstract
AIM
To assess the value of the mean systemic-to-pulmonary 
artery pressure (MAP/mPAP) ratio for predicting out-
comes following orthotopic liver transplant (OLT). 
METHODS
A retrospective data analysis was performed and 
data (mean arterial blood pressure, mean pulmonary 
artery pressure and Cardiac Index) were collected at 
several points during OLT. Outcomes evaluated were 
duration of postoperative endotracheal intubation 
[ET; minutes after intensive care unit (ICU) arrival], 
length of ICU stay, total hospitalization and frequency 
of immediate postoperative complications. A total of 
91 patients were included in the data analysis. Based 
on the intraoperative course of the MAP/mPAP ratio, 
2 hemodynamic responses were identified: Group 1 
(MAP/mPAP ratio increase during anhepatic period with 
postreperfusion recovery, n  = 66); and Group 2 (MAP/
mPAP ratio with no change during anhepatic period or 
decreased without recovery, n  = 25). 
RESULTS
The main finding was that the lack of increased MAP/
mPAP ratio in the anhepatic period was associated with: 
(1) longer intubation times; and (2) prolonged ICU 
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stays and total hospitalization time, when compared to 
patients with an increase in MAP/mPAP ratio during the 
anhepatic period. 
CONCLUSION
The data from this retrospective study should raise 
awareness to the mean systemic to pulmonary artery 
pressure ratio as a potential indicator for poor outcome 
after OLT. Further prospective studies are needed for 
validation. 
Key words: Anesthesiology; Liver transplantation; Right 
heart function; Outcome; Morbidity
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: The aim of this study was to assess the value 
of the mean systemic-to-pulmonary artery pressure 
(MAP/mPAP) ratio for predicting outcomes following 
orthotopic liver transplant. The intraoperative pattern of 
this ratio has not been previously described. Performing a 
retrospective analysis we identified 2 different MAP/mPAP 
patterns: Group 1 (MAP/mPAP ratio increase during 
anhepatic period with postreperfusion recovery, n = 66); 
and Group 2 (MAP/mPAP ratio with no change during 
anhepatic period or decreased without recovery, n = 25). 
The main finding was that the lack of increased MAP/
mPAP ratio in the anhepatic period was associated with 
longer intubation times, and prolonged hospitalization 
time. 
Rebel A, Nguyen D, Bauer B, Sloan PA, DiLorenzo A, Hassan 
ZU. Systemic-to-pulmonary artery pressure ratio as a predictor of 
patient outcome following liver transplantation. World J Hepatol 
2016; 8(32): 1384-1391  Available from: URL: http://www.
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INTRODUCTION
The mean systemic-to-pulmonary artery pressure 
ratio (MAP/mPAP) has been shown to be a valuable 
predictor of outcomes following cardiac surgery. Previous 
studies documented that the MAP/mPAP ratio was 
easy to obtain during cardiac surgery, and correlated 
with the development of pulmonary hypertension and 
diastolic dysfunction[1-4]. Outcomes following orthotopic 
liver transplant (OLT) are dependent on the ability of 
the patient’s cardiovascular system to compensate 
for the physiological stress related to OLT. While 
detailed and expensive cardiac evaluation is routinely 
performed on patients before OLT, the extent of 
cirrhotic cardiomyopathy and biventricular dysfunction 
is often underestimated[5,6]. Intraoperatively, due to 
circumstances related to advanced multi-organ disease, 
limited cardiac reserve and procedural related stressors 
including blood loss, fluid shifts, acidosis, or hypothermia, 
the patient may present more hemodynamic challenges 
than anticipated[7]. 
The MAP/mPAP ratio as a predictor of patient 
outcome following OLT has not been investigated. 
We hypothesized that the pattern of the MAP/mPAP 
ratio during the different stages of OLT may predict 
the ability of the circulatory system to compensate for 
the surgery related stress. If the MAP/mPAP pattern 
indicates sufficient cardiac reserve, the patient should 
have a better outcome than patients with a MAP/mPAP 
ratio that is less favorable. In order to more reliably risk 
stratify these patients undergoing OLT, we performed 
a retrospective data analysis to explore the feasibility 
of obtaining useable data during OLT. With desirable 
outcomes defined as less morbidity/mortality, decreased 
need for mechanical ventilation and shorter length of 
stay, the aim of this study was to assess the value of 
the MAP/mPAP ratio for predicting desirable outcomes 
following OLT. 
MATERIALS AND METHODS
The Institutional Review Board (IRB) reviewed the study 
protocol and gave approval access to an institutional 
database to retrieve patient information. The IRB 
waived the need for informed consent since the de-
identified data review demonstrated minimal risk to 
patient population. 
The retrospective data analysis was performed on 
patients undergoing OLT for end-stage liver disease in the 
time period from October 2011 through October 2014 
at a single University Hospital. All patients undergoing 
OLT during this time period regardless of underlying liver 
disease, model for end-stage liver disease (MELD) score 
and age were included. Exclusion criteria were patients 
undergoing OLT as a combined procedure with kidney 
transplant, redo-OLT or OLT as a treatment for acute liver 
failure. Patient records with incomplete intraoperative 
information were excluded from the data analysis. 
The selected time period was based on the absence 
of changes in surgical approach or staff (transplant 
surgeon/anesthesiology). All patients underwent cardiac 
evaluation with transthoracic echocardiography prior 
to listing for liver transplant. None of the included 
patients were diagnosed with or had signs of pulmonary 
hypertension prior to OLT. 
All OLT were performed using the end-to-end inferior 
vena cava (IVC) anastomosis technique requiring total 
IVC cross-clamp during the anhepatic period. Using this 
technique, the anhepatic period was less than 60 min for 
all OLTs in this study period. Intraoperative anesthesia 
care for all patients followed a standardized protocol for 
anesthesia induction, intravenous access, monitoring and 
vasoactive medications. All patients remained intubated 
at the conclusion of their surgical procedure and were 
transported to a dedicated intensive care unit (ICU) for 
anesthesia emergence and recovery. 
Patient demographic data were collected including 
preoperative creatinine level, comorbidities, MELD score, 
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age and gender. Basic intraoperative information such 
as procedure time, intraoperative intravenous fluids 
and blood component therapy were extracted from 
the surgical records. During the retrospective chart 
review, the following intraoperative hemodynamic data 
were gathered: Mean arterial blood pressure, mean 
pulmonary artery pressure and Cardiac Index (CI). These 
hemodynamic parameters were collected at several 
time points during the surgical procedure: Baseline (30 
min after incision), pre-anhepatic (1 h before IVC cross-
clamp), anhepatic (15 min before reperfusion), neo-
hepatic (15 min after reperfusion), and 1 h neo-hepatic (1 
h after reperfusion). 
MAP/mPAP patterns
Based on pilot observations, the MAP/mPAP ratio was 
expected to increase during the anhepatic phase. During 
the data analysis, patients indicating an increase in 
MAP/mPAP ratio by ≥ 1 from baseline to anhepatic 
phase were categorized into Group 1. Patients showing 
a decrease in MAP/mPAP ratio of ≥ -1 or no change 
(< 1 to > -1) from baseline to anhepatic phase were 
categorized into Group 2. We chose the anhepatic period 
as comparison to the baseline value because this surgical 
stage is characterized by a single hemodynamic alteration 
(preload reduction) and for a prolonged duration. In 
our institution, the anhepatic period is approximately 
45-55 min. Therefore, all patients received a similar 
type of cardiac stress. To account for fluctuations in this 
anhepatic period we chose a measurement point at 15 
min before reperfusion (IVC cross-clamp release) to 
allow sufficient equilibration time for reduction in cardiac 
preload caused by the IVC flow interruption.
Vasopressor use
Further chart review was performed regarding the 
use of vasoactive agents in the anhepatic phase of 
the operation. The following medications are available 
intraoperatively: Norepinephrine (NE), Epinephrine (EPI), 
Vasopressin (V), Dopamine (DOP) and Phenylephrine 
(PHE). Intraoperative documentation allowed the 
investigators to identify of the frequency and dosing of 
vasoactive medication at 30 to 15 min before reperfusion 
(anhepatic measurement of MAP/mPAP ratio). The 
patients were sorted into three categories: No vasoactive 
medication use, low dose vasoactive medication use (NE 
< 0.05 μ/kg per minute, EPI < 0.03 μg/kg per minute, V 
< 0.03 units/min, or PHE < 0.1 μg/kg per minute) and 
high dose vasoactive medication use (NE ≥ 0.05 μg/kg 
per minute, EPI ≥ 0.03 μg/kg per minute, V ≥ 0.03 
units/min or any vasopressor combination). 
Outcomes
The patient outcomes evaluated were duration of post-
operative endotracheal intubation (ET, minutes after ICU 
arrival), length of ICU stay (LOS ICU, days post OLT) 
and length of hospital stay (LOS Total, days post OLT to 
hospital discharge). Postoperative complications were 
recorded if they occurred in the first 14 postoperative 
days after OLT. The frequency of reintubation within 48 h 
post extubation, need for renal replacement therapy and 
the need for ICU readmission were recorded. Mortality < 
1 mo post OLT was also recorded. 
Data is reported as mean ± SD. Statistical analysis 
was performed by the paired t-test or χ 2 test. A P value 
of < 0.05 was used to identify statistical significance. 
RESULTS
A total of 100 patients were included in the study. Due 
to incomplete data recordings, 9 patients were excluded 
from data analysis. Thus, data from a total of 91 patients 
was included in this analysis. The demographic patient 
characteristics and characterization of intraoperative 
course are shown in Table 1. Age, gender and MELD 
scores were equally distributed in both groups. The 
most common causes for end-stage liver disease in 
our patient collective were Hepatitis C related liver 
cirrhosis (48 patients, Group 1: 35 patients; Group 2: 
13 patients), NASH related cirrhosis (21 patients, Group 
1: 16 patients; Group 2: 5 patients) and alcohol induced 
liver cirrhosis (25 patients, Group 1: 16 patients; Group 
2: 9 patients). Primary sclerosing cholangitis related liver 
cirrhosis was the leading diagnosis in 5 patients (all in 
Group 1). Other rare OLT indications were autoimmune 
hepatitis or alpha-trypsin 2 deficiency (one patient 
each, all Group 1). Two patients had hepato-pulmonary 
syndrome prior to OLT (both in Group 1). 
Pre-OLT Creatinine was not different between the 
two groups (Group 1: 1.26 ± 0.67 mg/dL, Group 2: 1.30 
± 0.82 mg/dL). There were no significant differences 
in surgical duration, fluid requirements or use of blood 
Age (yr) Gender (F:M ratio) MELD (score) OR duration (min) Crystalloid (mL) Colloid (mL) PRBC (units) FFP (units)
Group 1 (n = 66) 55.6 ± 8.6 24:42 (36%) 18.7 ± 8.4 400.9 ± 43.5 5804 ± 2824 1440 ± 972 3.3 ± 3.7 2.8 ± 3.0
Group 2 (n = 25) 58.9 ± 5.4   7:18 (28%) 16.3 ± 6.9 427.9 ± 63.3 6086 ± 3424 1607 ± 626 3.9 ± 3.1 4.0 ± 4.6
P-value 0.081 0.189 0.204 0.081 0.690 0.428 0.473 0.148
Table 1  Patient demographics and surgical characteristics
Data are shown as mean ± SD. P value was obtained using paired t-test for all parameters except gender. The 1-tail exact binomial calculation with 
probability value of 0.5. Group 1 (n = 66): Patients with MAP/mPAP ratio increase during anhepatic period; Group 2 (n = 25): Patients with MAP/mPAP 
ratio decrease or no change during anhepatic period. MELD: Model For End-Stage Liver Disease score; OR duration: Anesthesia time from induction to 
ICU transfer; Crystalloid: Amount of intraoperative normal saline; Colloid: Amount of intraoperative 5% Albumin; PRBC: Packed red blood concentrate; 
FFP: Fresh frozen plasma;  MAP/mPAP: Mean systemic-to-pulmonary artery pressure.
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component therapy between the patient collectives 
(Table 1). 
The intraoperative MAP/mPAP values for each group 
at the different measurement points are shown in 
Figure 1. MAP/mPAP values at baseline and at the prean-
hepatic period were slightly higher in Group 2 than in 
Group 1 (Table 2). However, the difference was not stati-
stically significant. Patients in Group 1 demonstrated a 
significant increase in MAP/mPAP during the anhepatic 
period. The MAP/mPAP ratio pattern in Group 2 showed 
less variability throughout the surgical procedure 
(Figure 1). The analysis of the absolute MAP/mPAP 
values indicated that MAP/mPAP recovered to baseline 
range after reperfusion in both groups. However, the 
percent change of MAP/mPAP ratio at baseline to the 
different measurement points indicated that MAP/mPAP 
recovered to baseline after reperfusion in Group 1. The 
percent change of MAP/mPAP ratio was significantly 
decreased in Group 2 after reperfusion, lasting up to 1 h 
post reperfusion (Table 2). In Group 1 the MAP/mPAP 
ratio increased by 2.9 ± 1.8 during the anhepatic period, 
while MAP/mPAP ratio in Group 2 only changed by 0.1 ± 
1.1 at this observation point. CI measurements did not 
parallel the hemodynamic patterns shown by the MAP/
mPAP ratio (Table 2). There were no significant changes 
in CI between both groups at any observation points 
during the surgical procedure. 
The majority of patients required vasoactive medication 
during the anhepatic phase and the presence of these 
medications may have influenced the hemodynamic 
measurements at the anhepatic measurement point 
(Table 3). Approximately 80% of patients in both 
groups received some vasopressor assistance during 
the anhepatic phase. Phenylephrine, Vasopressin and 
Norepinephrine were the most commonly used vaso-
pressors. While approximately half of patients required 
some low-dose vasoactive medication, the frequency 
Group 1 Group 2 P -value
MAP/mPAP increase during  anhepatic 
period (n  = 66)
MAP/mPAP no change or decrease during 
anhepatic period (n= 25)
MAP/mPAP baseline    3.32 ± 0.734     4.13 ± 1.191     0.185
% change preanhepatic  0.278 ± 1.276   0.184 ± 1.268     0.754
% change anhepatic  2.892 ± 1.827 -0.088 ± 1.137 < 0.01a
% change neohepatic  0.206 ± 1.411 -0.688 ± 1.325 < 0.01a
% change 1 h neohepatic  0.098 ± 0.828 -0.611 ± 1.373 < 0.01a
CI baseline  4.111 ± 1.229   4.214 ± 0.961     0.879
% change preanhepatic  0.039 ± 0.790 -0.204 ± 0.832     0.200
% change anhepatic -1.606 ± 1.018 -1.188 ± 1.082     0.089
% change neohepatic -0.327 ± 1.316 -0.058 ± 1.231     0.378
% change 1 h neohepatic  0.335 ± 1.106   0.454 ± 1.038     0.643
ET
   min    967 ± 1361   1719 ± 1933      0.040a
   h  16.1 ± 22.7 28.7 ± 32.2
Median (min) 540 1045
LOS ICU  (d)  3.9 ± 4.4   12.1 ± 19.2 < 0.01a
Median (d)     2       6
LOS hospital (d)  12.0 ± 12.5  26.3 ± 33.2 < 0.01a
Median (d)     8     11
Table 2  Mean systemic-to-pulmonary artery pressure ratio and cardiac index, measured at several times during the liver transplant: 
Baseline (30 min after incision), preanhepatic (1 h before inferior vena cava cross-clamp), anhepatic (15 min before reperfusion), 
neohepatic (15 min after reperfusion), and 1 h neohepatic (1 h after reperfusion)
% change is calculated as difference from value to baseline value; data are shown as mean ± SD, and median value for ET and LOS. P value was obtained 
using paired t-test. aP < 0.05. ET (duration of postoperative endotracheal intubation): Minutes from ICU arrival to extubation to supplemental oxygen; 
LOS ICU: Length of stay in intensive care unit; LOS total: Time from ICU arrival to hospital discharge; MAP/mPAP: Mean systemic-to-pulmonary artery 
pressure ratio; CI: Cardiac index.
Group 1
Group 2
9
8
7
6
5
4
3
2
M
AP
/m
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P 
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Baseline      Preanheptic    Anhepatic    Neohepatic  1 h neohepatic
Study measurement intervals
Figure 1  Mean systemic-to-pulmonary artery pressure ration. MAP/mPAP 
= Mean systemic-to-pulmonary artery pressure ratio, measured at several times 
during the liver transplant: Baseline (30 min after incision), preanhepatic (1 h 
before IVC cross-clamp), anhepatic (15 min before reperfusion), neohepatic (15 
min after reperfusion), and 1 h neohepatic (1 h after reperfusion). Group 1 (n = 
66): Patients with MAP/mPAP ratio increase during anhepatic period; Group 2 (n 
= 25): Patients with MAP/mPAP ratio decrease or no change during anhepatic 
period. Data are shown as mean ± SD. P value was obtained using paired 
t-test. IVC: Inferior vena cava; MAP/mPAP: Mean systemic-to-pulmonary artery 
pressure.
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and severity of vasopressor support was not different 
between Group 1 and 2. 
There were significant differences in duration of 
postoperative intubation, length of stay in the ICU and 
length of hospital stay between Group 1 and Group 2 
(Table 2). Patients in Group 1 extubated on an average 
of 12 h earlier than the patients in Group 2 (16.1 ± 
22.7 h vs 28.7 ± 32.2 h, respectively; P = 0.04). The 
duration of ICU stay was reduced by almost 8 d (Group 
1: 3.9 ± 4.4 d, Group 2: 12.1 ± 19.2; P < 0.01). Total 
length of hospitalization was approximately 2 wk less in 
Group 1 than in Group 2 (12.0 ± 12.5 d vs 26.3 ± 33.2 d, 
respectively; P < 0.01).
In the immediate post OLT period (up to 30 d posto-
peratively) no mortality was reported in either group. 
In Group 1 four out of 66 patients (6%) required 
reintubation and five out of 66 patients (8%) received 
RRT; no other complications were reported in this group. 
In Group 2 three out of 25 patients (12%) required 
reintubation and seven out of 25 patients (28%) received 
RRT post OLT. One patient was readmitted to ICU and 
one patient developed seizures. 
DISCUSSION
The main finding of this study was that despite having 
similar preoperative pathophysiology, one quarter of 
patients undergoing OLT did not display the expected 
increase of MAP/mPAP ratio during the anhepatic phase. 
This lack of increased MAP/mPAP ratio in the anhepatic 
period by > 1 compared to baseline values was asso-
ciated with: (1) longer duration of postoperative intuba-
tion; and (2) prolonged ICU stay and total hospitalization 
time when compared to patients with an increase in 
MAP/mPAP ratio during the anhepatic period. The changes 
in MAP/mPAP ratio were not mirrored by CI, thus the 
intraoperative pattern of MAP/mPAP may be predictive 
of patient clinical outcomes after liver transplantation. 
To our knowledge, this is the first study to describe the 
intraoperative pattern of MAP/mPAP ratio during liver 
transplant and its possible relationship with patient 
outcomes following OLT.
Advanced liver disease has been known to affect 
other organ functions, most importantly the cardiova-
scular and renal systems[8,9]. The connection between 
liver cirrhosis and cardiac dysfunction has been previously 
recognized[8,10-12] as recent studies have documented 
that cirrhosis is associated with biventricular systolic 
dysfunction[5,6]. It is standard practice for patients to 
undergo an extensive preoperative cardiac evaluation to 
risk stratify them prior to listing for liver transplantation. 
The echocardiographic assessment and stress testing is 
usually centered on left ventricular function. While right 
ventricular systolic pressure and or Tricuspid annular 
plane systolic excursion is usually measured to evaluate 
the patient for right heart function and pulmonary 
hypertension; neither of these parameters correlates well 
with right systolic function[5]. Advanced echocardiography 
techniques (strain analysis/right ventricle relative area 
change) are rarely included in the standard pre OLT 
echocardiography assessment[5,13]. 
Cardiologists commonly use the MAP/mPAP ratio to 
stratify the severity of pulmonary hypertension because 
it describes the close relationship between systemic 
and pulmonary circulations[14]. Preoperative value of 
MAP/mPAP < 4 would be of concern for cardiologists for 
possible pulmonary hypertension, and MAP/mPAP values 
< 4 have been correlated with lower survival rates after 
cardiac surgery[2,15]. We used the MAP/mPAP ratio in 
this study to assess its value to predict outcomes after 
liver transplantation, since this parameter has shown 
to be a useful predictor of hemodynamic complications 
after cardiac surgery[2]. Our data confirm the previous 
findings of the use of MAP/mPAP to identify patients at 
risk for adverse events after high-risk surgery. In this 
study, the intraoperative hemodynamic MAP/mPAP 
pattern of patients undergoing OLT indicated that an 
increase in MAP/mPAP during the anhepatic phase is 
associated with better outcomes. A novelty of this report 
is the analysis of the MAP/mPAP ratio intraoperative 
pattern and correlating it with postoperative outcomes. 
While our reported data are truly observational, it is 
Group 1 Group 2 P -value
Vasopressor use frequency MAP/mPAP increase during 
anhepatic period (n  = 66)
MAP/mPAP no change or decrease 
during anhepatic period (n  = 25)
No vasopressor use 14   5 0.624
Low dose vasopressor use 39 12 0.341
High dose vasopressor use 13   8 0.214
Table 3  Vasopressor use
Following medications are intraoperatively available: Norepinephrine (NE), Epinephrine (EPI), Vasopressin 
(V), Dopamine or Phenylephrine (PHE). Based on intraoperative documentation at 15 min before reperfusion 
(anhepatic measurement of MAP/mPAP ratio). The patients were sorted into three different categories: 
No vasoactive medication use; low dose vasoactive medication use (NE < 0.05 mcg/kg per minute or EPI 
< 0.03 mcg/kg per minute or V < 0.03 units/min or PHE < 0.1 μg/kg per minute) and high dose vasoactive 
medication use (NE ≥ 0.05 μg/kg per minute, EPI ≥ 0.03 μg/kg per minute, V ≥ 0.03 units/min or any 
vasopressor combination). Data are shown as patient number receiving vasopressor therapy at the anhepatic 
measurement point (15 min before reperfusion).  P value was obtained using χ 2 test. A P-value for < 0.05 was 
set for statistical significance. MAP/mPAP: Mean systemic-to-pulmonary artery pressure.
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not well established what significance the MAP/mPAP 
ratio represents, especially in patients with advanced 
liver disease. Cardiologists have set a normal value of > 
4[14]. The observation that the majority of the included 
patients in our study had values < 4 in absence of 
pulmonary hypertension may be due to advanced liver 
disease or the effect of anesthetic medications, since 
the baseline measurements were taken post induction 
of anesthesia. Previous studies indicated only minor 
effect of anesthesia on the MAP/mPAP ratio[2]. However, 
patients with advanced liver disease may have lower 
numbers due to systemic vasodilation and may have an 
exaggerated vascular response to anesthetics. 
A recent study from Bushyhead et al[16] investigated 
preoperative data of liver transplant recipients and found 
that the pulmonary artery systolic pressure correlates 
with posttransplant outcome and therefore emphasized 
the importance of right ventricular assessment and 
pulmonary vascular resistance for the morbidity and 
mortality associated with the procedure. However, the 
publication did not assess the value of the MAP/mPAP 
ratio for preoperative risk stratification. While our study 
did not obtain preoperative MAP/mPAP values prior 
to anesthesia induction and did not include patients 
with pre-existing pulmonary hypertension defined by 
elevated pulmonary artery pressures, the findings of our 
study support the need for more thorough assessment 
of right heart function and cardiac reserve prior to 
liver transplantation. With the scarcity of acceptable 
donor organs, the best surgical candidate with the 
least likelihood for postoperative complication needs 
to be identified. Including MAP/mPAP ratio into the 
preoperative assessment may provide useful information. 
Minimizing the importance of a single measurement 
and focusing on the intraoperative patterns of the 
MAP/mPAP ratio, the trend of the parameter may be 
interpreted as an indication of contractility reserve. The 
hemodynamic hallmark of the anhepatic phase during 
liver transplantation is characterized by significant 
reduction in IVC flow and therefore blood return to 
the heart. The behavior of MAP/mPAP ratio during the 
anhepatic phase therefore may indicate the systemic 
and pulmonary circulatory response during reduced 
cardiac preload. An increase in MAP/mPAP ratio may 
suggest that circulatory systems are able to adjust to 
stress and hypovolemia by vasoconstriction and inotropic 
compensation. Therefore, the ability to increase the MAP/
mPAP ratio in the anhepatic phase observed in Group 1 
indicates better cardiovascular reserve than the lack of 
increase or decrease as observed in Group 2. 
We chose to use the MAP/mPAP ratio difference 
between baseline and anhepatic phase because the 
anhepatic stage primarily represents a single hemody-
namic alteration (preload reduction). Therefore, all 
patients received a similar type of cardiac stress and the 
MAP/mPAP ratio may be more representative for the 
cardiac ability to compensate for the preload reduction. 
Although hepatic reperfusion can cause significant cardiac 
strain, the cardiac response to reperfusion depends 
on multiple factors and some of them may be due to 
the donor organ. The duration of reperfusion is usually 
short and therefore changes in MAP/mPAP may be 
not reflecting the cardiac response to the changes in 
preload, cardiac contractility or afterload. Our study used 
single MAP/mPAP ratio measurements at predetermined 
measurement point representing the hemodynamic 
situation during the surgical stage. Due to the fluctuating 
nature of all hemodynamic parameters during OLT, a 
continuous assessment of MAP/mPAP ratio throughout 
the entire surgical procedure may be more desirable in 
future studies to describe the cardiac reserve. 
In our study, vasoactive medications were not con-
trolled during the surgical procedure, and were titrated to 
effect by the anesthesia provider to ensure hemodynamic 
stability. Variable doses of vasoactive medications were 
given in both study groups. However, drug selection and 
dosing did not appear to influence the MAP/mPAP pattern 
since there were no statistical differences in distribution 
between both groups. 
In previous studies on cardiac patients without pre-
existing pulmonary hypertension, a low MAP/mPAP 
ratio was found to be an independent predictor of 
difficult separation of cardiopulmonary bypass and right 
heart failure[2,17]. Robitaille et al[2] found that patients 
with lower MAP/mPAP ratios had more hemodynamic 
complications after cardiac surgery defined as cardiac 
arrest, vasopressor therapy > 24 h postop, and/or use 
of intra-aortic balloon pump postop. These findings are 
in agreement with our interpretation of MAP/mPAP ratio 
as a predictor of the ability of the cardiovascular system 
to provide hemodynamic compensation. If a MAP/mPAP 
increase during the anhepatic phase is interpreted as a 
positive cardiovascular response to stressors, the lack 
of such compensation would explain why the patients 
without such a response would have less favorable 
outcomes. 
Robitaille et al[2] correlated the preoperative MAP/
mPAP ratio with surgical outcome after cardiac surgery 
and reported that the preoperative MAP/mPAP ratio 
was significantly higher in survivors (3.9 ± 1.4) than in 
those who died (3.2 ± 1.4). Since the surgical procedure 
during liver transplantation has more complexity and 
varying hemodynamic challenges specific to each surgical 
phase, we chose (per expert consensus) observation 
points to describe the MAP/mPAP pattern throughout 
different surgical stages of the procedure. Our pattern 
analysis confirms the findings of the single preoperative 
measurement in the previous study[2]. However, our 
observation and current understanding of the ratio is that 
it is not a static parameter and, per our data, large ratio 
fluctuations can occur and should alert the clinician to 
initiate an adjustment in the treatment plan. 
Our study has several limitations. First, all data 
was gathered as a retrospective study from only one 
institution without randomization or blinding. The normal 
hemodynamic response was defined by the authors 
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based on preliminary observations and understanding 
of hemodynamic response to the IVC flow alterations 
during the anhepatic phase. However, this categorization 
may be oversimplified to demonstrate the variety of 
possible dynamic responses in the anhepatic period. The 
study was also limited by data analysis. The data was 
not measured continuously, as we selected the ratio of 
mean systemic to pulmonary artery pressure at defined 
time points during the liver transplant. Our endpoint data 
(time to extubation in ICU, LOS ICU, etc.) could have 
also been affected by variability in ICU provider practice. 
Certain providers may not have been as aggressive as 
other providers in extubating patients. In addition, there 
are other factors that affect duration of endotracheal 
intubation, such as failure to extubate due to opioid 
induced apnea. All these variables are not factored into 
this study. 
If future prospective trials confirm the value of intra-
operative MAP/mPAP ratio patterns for postoperative 
outcome prediction, the question will arise if MAP/mPAP 
ratio manipulation may be able to alter the outcome 
after major surgery. Increasing MAP with vasopressor/
inotropic medications or lowering mPAP with pulmonary 
vasodilators could be beneficial. 
In conclusion, the data of this retrospective study 
raises awareness of the mean systemic to mean pulmo-
nary artery pressure ratio during surgery as a potential 
indicator for poor patient outcome following OLT. To 
further delineate the significance of this parameter, a 
multi-center, randomized, blinded prospective study 
with more frequent measurement points is needed for 
validation. 
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